[Disturbances of coagulation following high-dosage methotrexate with citrovorum factor rescue in patients with osteogenous sarcoma. (author's transl)].
D001219:Aspartate Aminotransferases / Q000097:blood; D001779:Blood Coagulation Factors / Q000032:analysis; D002648:Child; D004211:Disseminated Intravascular Coagulation / Q000139:chemically induced* / Q000188:drug therapy; D005260:Female; D006493:Heparin / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D002955:Leucovorin / Q000008:administration & dosage / Q000009:adverse effects*; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects* / Q000097:blood; D012516:Osteosarcoma / Q000188:drug therapy*
D001779:Blood Coagulation Factors; D006493:Heparin; D001219:Aspartate Aminotransferases; D002955:Leucovorin; D008727:Methotrexate
Gerinnungsstörungen nach hochdosiertem Methotrexat mit Citrovorum Factor Rescue bei Patienten mit osteogenem Sarkom.